Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
37 studies found for:    eisai alzheimer's
Show Display Options
Rank Status Study
1 Completed
Has Results
Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 23 mg SR in Study 326;   Drug: 10 mg IR in Study 326
2 Completed
Has Results
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aricept (donepezil SR 23 mg);   Drug: Aricept (donepezil IR 10 mg)
3 Recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
4 Recruiting Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice-
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride (Aricept)
5 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A
6 Completed Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: Donepezil hydrochloride
7 Completed
Has Results
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil
8 Completed EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
9 Completed The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Condition: Mild to Severe Alzheimer's Disease
Intervention: Drug: Donepezil HCl
10 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
11 Active, not recruiting Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
12 Recruiting Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease -
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
13 Active, not recruiting A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020;   Drug: Placebo
14 Completed
Has Results
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
15 Active, not recruiting Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
Condition: Alzheimer's Type Dementia
Intervention: Drug: E2020
16 Completed Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Condition: Alzheimer's Disease
Intervention: Drug: Donepezil Hydrochloride
17 Active, not recruiting Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
18 Completed Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
Conditions: Dementia;   Alzheimer's Disease
Intervention: Drug: Rasagiline
19 Completed Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
Condition: Alzheimer's Disease
Interventions: Drug: Experimental 1;   Drug: Placebo Comparator
20 Terminated Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients
Condition: Alzheimer's Disease
Intervention: Drug: DONEPEZIL HYDROCHLORIDE

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years